Atıf Formatları
The Validation of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria in a Cohort from Turkey
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

S. Mısırcı Et Al. , "The Validation of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria in a Cohort from Turkey," Diagnostics , vol.14, no.19, 2024

Mısırcı, S. Et Al. 2024. The Validation of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria in a Cohort from Turkey. Diagnostics , vol.14, no.19 .

Mısırcı, S., Ekin, A., YAĞIZ, B., COŞKUN, B. N., DALKILIÇ, H. E., & PEHLİVAN, Y., (2024). The Validation of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria in a Cohort from Turkey. Diagnostics , vol.14, no.19.

Mısırcı, Salim Et Al. "The Validation of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria in a Cohort from Turkey," Diagnostics , vol.14, no.19, 2024

Mısırcı, Salim Et Al. "The Validation of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria in a Cohort from Turkey." Diagnostics , vol.14, no.19, 2024

Mısırcı, S. Et Al. (2024) . "The Validation of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria in a Cohort from Turkey." Diagnostics , vol.14, no.19.

@article{article, author={Salim Mısırcı Et Al. }, title={The Validation of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria in a Cohort from Turkey}, journal={Diagnostics}, year=2024}